Pubertal Suppression in Transgender Youth, 1e

Pubertal Suppression in Transgender Youth, 1e

502 Lei 462 Lei(TVA inclus)
Livrare gratis la comenzi peste 500 RON. Pentru celelalte comenzi livrarea este 20 RON.

Cod produs/ISBN: 9780323569637

Disponibilitate: La comanda in aproximativ 4 saptamani

Editura: Elsevier

Limba: Engleza

Nr. pagini: 116

Coperta: Paperback

Dimensiuni: 18.4 x 1.3 x 22.9 cm

An aparitie: 07-Aug-18


Offering current guidelines on the relatively new practice of puberty suppression for gender-dysphoric adolescents, Pubertal Suppression in Transgender Youth provides a succinct, easy-to-digest overview of this timely topic. This concise, clinically-focused resource by Dr. Courtney Finlayson covers all relevant topics, from a brief history of medical care of transgender youth to emerging developments in the field.


 Table of Contents


·  Copyright

·  List of Contributors

·  Chapter 1. History of Care of Transgender Youth

·  Dedication

·  Chapter 2. Models of Care and Current Guidelines for Care of Transgender Individuals

·  Gender-Affirming Care

·  Multidisciplinary Care

·  Practice Guidelines

·  Mental Healthcare

·  Medical Care

·  Adjunctive Services

·  Barriers to Care

·  Summary

·  Chapter 3. Puberty

·  Physical Changes Associated With Puberty

·  Physiology of Puberty

·  Delayed Puberty or Absent Puberty (Sexual Infantilism)

·  Precocious Puberty (Sexual Precocity)

·  Chapter 4. GnRH Analogs (Mechanism, Past Studies, Drug Options, Use in Precocious Puberty, Use in Gender-Nonconforming Youth)

·  Historical Perspective

·  Physiology and Mechanism of Action

·  Use in Central Precocious Puberty

·  Outcomes in Central Precocious Puberty

·  Use in Gender-Nonconforming Youth

·  Options for Treatment

·  Outcomes in Gender-Nonconforming Youth

·  Challenges in Care

·  Conclusion

·  Chapter 5. Rationale for the Initiation, Use, and Monitoring of GnRHa in Gender Non-conforming Youth

·  Introduction

·  Rationale

·  Initiation

·  Monitoring

·  Conclusion

·  Chapter 6. Psychosocial Considerations in Pubertal Suppression Treatment

·  Introduction

·  Possible Effects of Gonadotropin-Releasing Hormone Analogues on Gender Identity and/or Sexuality Development

·  Unknown Neurocognitive Sequelae of Pubertal Suppression Treatment

·  Psychosocial Implications of Known Medical Side Effects of Gonadotropin-Releasing Hormone Analogue Treatment

·  Family Factors

·  Conclusion

·  Chapter 7. Medical Side Effects of GnRH Agonists

·  Bone Health

·  Brain

·  Fertility

·  Body Mass Index and Body Composition

·  Summary

·  Chapter 8. Surgical Side Effects of GnRHa

·  Introduction

·  Goals of Surgery

·  Timing of Surgery

·  Surgical Considerations for Individuals on GnRHa

·  Areas of Uncertainty

·  Conclusion

·  Chapter 9. Fertility Preservation: Considerations for Gender-Diverse Youth

·  Risk of Infertility due to Hormonal Therapies

·  Fertility Preservation Options in Birth-Assigned Males

·  Fertility Preservation Options in Birth-Assigned Females

·  Attitudes Toward FP and Other Psychological Considerations

·  Ethical Considerations

·  Financial Considerations

·  Future Directions

·  Conclusions

·  Chapter 10. Duration of Pubertal Suppression and Initiation of Gender-Affirming Hormone Treatment in Youth

·  Pubertal Suppression and Gender-Affirming Hormone Therapies

·  Relevant Time Points in Clinical Guidelines and Protocols

·  Unresolved Questions

·  Case Examples

·  Initiation of Gender-Affirming Hormones

·  Testosterone

·  Estrogen

·  Conclusions

·  Chapter 11. Ethical Considerations of GnRHa Treatment and Consent Process

·  Introduction

·  Pubertal Suppression

·  Benefits of Pubertal Suppression

·  Ethical Issues

·  Conclusion

·  Chapter 12. Emerging Developments in Pubertal Suppression for Gender Incongruent/Gender Dysphoric Youth

·  Triptorelin, a New Gonadotropin-Releasing Hormone Agonist

·  Prolonged Use of Histrelin acetate implant in Transgender Youth

·  Gonadotropin-Releasing Hormone Agonist Use in Nonbinary Youth

·  Gonadotropin-Releasing Hormone and Gonadotropin Antagonists

·  Kisspeptin and Neurokinin B Antagonists

·  Oxandrolone as an Alternative Gender-Affirming Masculinizing Hormone

·  Low-Dose Estrogen and Testosterone

·  Antiandrogens and Androgen Receptor Inhibitors

·  Antiandrogens

·  Conclusion

An aparitie 07-Aug-18
Autor Courtney Finlayson MD
Dimensiuni 18.4 x 1.3 x 22.9 cm
Editura Elsevier
Format Paperback
ISBN 9780323569637
Limba Engleza
Nr pag 116

Clientii nu au adaugat inca opinii pentru acest produs. Fii primul care adauga o parere, folosind formularul de mai jos.

Spune-ne parerea ta despre acest produs

Nota acordata produsului:

Notificare prin e-mail cand apar comentarii noi